Ciphergen Biosystems(CIPH): Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH):

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mact who started this subject	1/3/2004 5:52:54 PM
From: John McCarthy	Read Replies (1) of 510

2003 - Ciphergen - Alzheimer's Study Presented Alzheimer's Study Presented. At the Society for Neuroscience Meeting 33rd Annual Meeting, Ciphergen reported the discovery of a novel multi-biomarker pattern derived from analyzing cerebral spinal fluid which correctly classified >96% of Alzheimer's Disease and >94% normal individuals using a 4 peak pattern of markers. Further studies analyzing over 200 additional samples are underway to validate these markers for their utility in diagnosing early stage Alzheimer's disease as well as in differentiating from other dementias using the Ciphergen platform. nachrichten.boerse.de note:Paul Freiman gave a presentation at Red Chip and wrote that there was an estimated 14 million people in the world with AD. additionally - it would be useful to note if their thingy could be used on other types of dementia .... John McCarthy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next